KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Other Non-Current Liabilities (2016 - 2026)

Novartis Ag's Other Non-Current Liabilities history spans 15 years, with the latest figure at -$100.0 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities changed N/A to -$100.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$100.0 million, a N/A change, with the full-year FY2025 number at $4.1 billion, up 1.42% from a year prior.
  • Other Non-Current Liabilities hit -$100.0 million in Q1 2026 for Novartis Ag, down from $4.1 billion in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for NVS hit a ceiling of $5.4 billion in Q2 2022 and a floor of -$100.0 million in Q1 2026.
  • Historically, Other Non-Current Liabilities has averaged $3.2 billion across 5 years, with a median of $4.1 billion in 2025.
  • Biggest five-year swings in Other Non-Current Liabilities: fell 14.93% in 2022 and later soared 406.84% in 2024.
  • Tracing NVS's Other Non-Current Liabilities over 5 years: stood at $874.0 million in 2022, then decreased by 8.01% to $804.0 million in 2023, then soared by 406.84% to $4.1 billion in 2024, then increased by 1.42% to $4.1 billion in 2025, then tumbled by 102.42% to -$100.0 million in 2026.
  • Business Quant data shows Other Non-Current Liabilities for NVS at -$100.0 million in Q1 2026, $4.1 billion in Q4 2025, and $4.2 billion in Q2 2025.